| 141.75 0.08 (0.06%) | 11-11 15:50 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 168.13 | 1-year : | 196.38 |
| Resists | First : | 143.94 | Second : | 168.13 |
| Pivot price | 141.49 |
|||
| Supports | First : | 138.36 | Second : | 134.91 |
| MAs | MA(5) : | 140.99 |
MA(20) : | 141.17 |
| MA(100) : | 134.16 |
MA(250) : | 123.98 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 47 |
D(3) : | 38.5 |
| RSI | RSI(14): 54.3 |
|||
| 52-week | High : | 143.94 | Low : | 100.11 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GMF ] has closed below upper band by 43.9%. Bollinger Bands are 18.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 141.89 - 142.69 | 142.69 - 143.41 |
| Low: | 138.7 - 139.76 | 139.76 - 140.73 |
| Close: | 140.14 - 141.67 | 141.67 - 143.07 |
The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in depositary receipts based on securities comprising the index. The index is a float-adjusted market capitalization weighted index designed to define and measure the investable universe of publicly traded companies domiciled in emerging Asian Pacific markets. The fund is non-diversified.
Wed, 15 Oct 2025
Best SPDR ETFs to Buy and Hold - Kiplinger
Tue, 30 Sep 2025
From Defensive to Dynamic: Utilities Join the Year-End Rally. 3 Stocks With Enticing Charts - Barron's
Tue, 16 Sep 2025
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Sun, 07 Sep 2025
If You'd Invested $1,000 in the SPDR S&P 500 ETF Trust (SPY) 10 Years Ago, Here's How Much You'd Have Today - sharewise.com
Thu, 28 Aug 2025
Inside XBI: What The SPDR S&P Biotech ETF Offers Investors (NYSEARCA:XBI) - Seeking Alpha
Mon, 04 Aug 2025
Is SPDR Portfolio S&P 500 High Dividend ETF Your Ticket to Becoming a Millionaire? - MSN
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |